FADS2 and Crohn disease: FADS2 modulates the inflammatory response by influencing metabolic pathways.[13] Restoration of FADS2 expression has been shown to reduce pro‐inflammatory macrophage infiltration and suppress inflammatory mediators in diseases such as Crohn's disease, highlighting its potential therapeutic relevance.[7]